Effect of food on pharmacokinetics of ACC017, a novel HIV‐1 integrase inhibitor, in healthy adult subjects

Documenti analoghi

• Single‐dose pharmacokinetics and safety of ACC017, a novel HIV integrase inhibitor, in healthy adult participants: A first‐in‐human study
  di: C. Hu, et al.
  Pubblicazione: (2025)
• Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS‐1893, a cardiac myosin inhibitor, in healthy subjects
  di: Kexu Yang, et al.
  Pubblicazione: (2026)
• Effect of fluconazole on the pharmacokinetics of ainuovirine in healthy adult subjects
  Pubblicazione: (2024)
• Antiviral activity, safety and PK/PD of ACC017 in antiretroviral naïve HIV‐infected adults: A randomized, double‐blind, placebo/dose‐parallel‐controlled short‐term monotherapy study
  di: N. Han, et al.
  Pubblicazione: (2025)
• Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjects
  di: Zi‐yi Zhou, et al.
  Pubblicazione: (2026)